Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/306% above fair value
$36.16−0.55 (-1.50%)
Close on Nov 18, 2026Market cap $2.77BP/E 39.3Yield –
Progyny free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Progyny's free cash flow for the twelve months ending Jun 30, 2026 was $178.38M, down 6.2% year over year. For fiscal 2025 it was $191.78M, up 10.4% from the year before. The highest annual figure on record is $191.78M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $191.78M | +10.4% |
| FY2024 | Dec 31, 2024 | $173.70M | -6.2% |
| FY2023 | Dec 31, 2023 | $185.17M | +140.0% |
| FY2022 | Dec 31, 2022 | $77.15M | +222.7% |
| FY2021 | Dec 31, 2021 | $23.91M | -32.0% |
| FY2020 | Dec 31, 2020 | $35.17M | – |
| FY2019 | Dec 31, 2019 | -$4.49M | -365.2% |
| FY2018 | Dec 31, 2018 | $1.69M | – |
| FY2017 | Dec 31, 2017 | -$10.09M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $44.21M | -12.0% |
| Q1 FY2026 | Mar 31, 2026 | $39.60M | -15.7% |
| Q4 FY2025 | Dec 31, 2025 | $48.59M | -3.3% |
| Q3 FY2025 | Sep 30, 2025 | $45.99M | +7.6% |
| Q2 FY2025 | Jun 30, 2025 | $50.24M | -10.0% |
| Q1 FY2025 | Mar 31, 2025 | $46.97M | +88.8% |
| Q4 FY2024 | Dec 31, 2024 | $50.27M | +35.9% |
| Q3 FY2024 | Sep 30, 2024 | $42.72M | -19.7% |
| Q2 FY2024 | Jun 30, 2024 | $55.83M | -25.8% |
| Q1 FY2024 | Mar 31, 2024 | $24.88M | +26.2% |
| Q4 FY2023 | Dec 31, 2023 | $36.98M | -27.2% |
| Q3 FY2023 | Sep 30, 2023 | $53.23M | +170.8% |
| Q2 FY2023 | Jun 30, 2023 | $75.25M | +301.2% |
| Q1 FY2023 | Mar 31, 2023 | $19.71M | – |
| Q4 FY2022 | Dec 31, 2022 | $50.80M | +519.2% |
| Q3 FY2022 | Sep 30, 2022 | $19.65M | -16.2% |
| Q2 FY2022 | Jun 30, 2022 | $18.76M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.05M | -7493.9% |
| Q4 FY2021 | Dec 31, 2021 | $8.20M | +27.4% |
| Q3 FY2021 | Sep 30, 2021 | $23.45M | +54.4% |
| Q2 FY2021 | Jun 30, 2021 | -$7.90M | -476.5% |
| Q1 FY2021 | Mar 31, 2021 | $163.00K | -98.6% |
| Q4 FY2020 | Dec 31, 2020 | $6.44M | – |
| Q3 FY2020 | Sep 30, 2020 | $15.18M | +178.1% |
| Q2 FY2020 | Jun 30, 2020 | $2.10M | -49.0% |
| Q1 FY2020 | Mar 31, 2020 | $11.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.77M | -298.2% |
| Q3 FY2019 | Sep 30, 2019 | $5.46M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.11M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.30M | – |
| Q4 FY2018 | Dec 31, 2018 | $3.92M | – |
See a number that looks wrong?